Global Radiopharmaceutical Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Radiopharmaceutical Therapy Industry Forecast” looks at past sales and reviews total world Radiopharmaceutical Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Radiopharmaceutical Therapy sales for 2023 through 2029. With Radiopharmaceutical Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceutical Therapy industry.
This Insight Report provides a comprehensive analysis of the global Radiopharmaceutical Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radiopharmaceutical Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radiopharmaceutical Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceutical Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceutical Therapy.
The global Radiopharmaceutical Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Radiopharmaceutical Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Radiopharmaceutical Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Radiopharmaceutical Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Radiopharmaceutical Therapy players cover Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Radiopharmaceutical Therapy Industry Forecast” looks at past sales and reviews total world Radiopharmaceutical Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Radiopharmaceutical Therapy sales for 2023 through 2029. With Radiopharmaceutical Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceutical Therapy industry.
This Insight Report provides a comprehensive analysis of the global Radiopharmaceutical Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radiopharmaceutical Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radiopharmaceutical Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceutical Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceutical Therapy.
The global Radiopharmaceutical Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Radiopharmaceutical Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Radiopharmaceutical Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Radiopharmaceutical Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Radiopharmaceutical Therapy players cover Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Actinium-225
- Lutetium-177
- Radium-223
- Holmium-166
- Other
- Oncology
- Cardiology
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceutical Therapy Market Size 2018-2029
2.1.2 Radiopharmaceutical Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Radiopharmaceutical Therapy Segment by Type
2.2.1 Actinium-225
2.2.2 Lutetium-177
2.2.3 Radium-223
2.2.4 Holmium-166
2.2.5 Other
2.3 Radiopharmaceutical Therapy Market Size by Type
2.3.1 Radiopharmaceutical Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
2.4 Radiopharmaceutical Therapy Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceutical Therapy Market Size by Application
2.5.1 Radiopharmaceutical Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
3 RADIOPHARMACEUTICAL THERAPY MARKET SIZE BY PLAYER
3.1 Radiopharmaceutical Therapy Market Size Market Share by Players
3.1.1 Global Radiopharmaceutical Therapy Revenue by Players (2018-2023)
3.1.2 Global Radiopharmaceutical Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Radiopharmaceutical Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICAL THERAPY BY REGIONS
4.1 Radiopharmaceutical Therapy Market Size by Regions (2018-2023)
4.2 Americas Radiopharmaceutical Therapy Market Size Growth (2018-2023)
4.3 APAC Radiopharmaceutical Therapy Market Size Growth (2018-2023)
4.4 Europe Radiopharmaceutical Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Radiopharmaceutical Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Radiopharmaceutical Therapy Market Size by Country (2018-2023)
5.2 Americas Radiopharmaceutical Therapy Market Size by Type (2018-2023)
5.3 Americas Radiopharmaceutical Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceutical Therapy Market Size by Region (2018-2023)
6.2 APAC Radiopharmaceutical Therapy Market Size by Type (2018-2023)
6.3 APAC Radiopharmaceutical Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Radiopharmaceutical Therapy by Country (2018-2023)
7.2 Europe Radiopharmaceutical Therapy Market Size by Type (2018-2023)
7.3 Europe Radiopharmaceutical Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceutical Therapy by Region (2018-2023)
8.2 Middle East & Africa Radiopharmaceutical Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Radiopharmaceutical Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RADIOPHARMACEUTICAL THERAPY MARKET FORECAST
10.1 Global Radiopharmaceutical Therapy Forecast by Regions (2024-2029)
10.1.1 Global Radiopharmaceutical Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Radiopharmaceutical Therapy Forecast
10.1.3 APAC Radiopharmaceutical Therapy Forecast
10.1.4 Europe Radiopharmaceutical Therapy Forecast
10.1.5 Middle East & Africa Radiopharmaceutical Therapy Forecast
10.2 Americas Radiopharmaceutical Therapy Forecast by Country (2024-2029)
10.2.1 United States Radiopharmaceutical Therapy Market Forecast
10.2.2 Canada Radiopharmaceutical Therapy Market Forecast
10.2.3 Mexico Radiopharmaceutical Therapy Market Forecast
10.2.4 Brazil Radiopharmaceutical Therapy Market Forecast
10.3 APAC Radiopharmaceutical Therapy Forecast by Region (2024-2029)
10.3.1 China Radiopharmaceutical Therapy Market Forecast
10.3.2 Japan Radiopharmaceutical Therapy Market Forecast
10.3.3 Korea Radiopharmaceutical Therapy Market Forecast
10.3.4 Southeast Asia Radiopharmaceutical Therapy Market Forecast
10.3.5 India Radiopharmaceutical Therapy Market Forecast
10.3.6 Australia Radiopharmaceutical Therapy Market Forecast
10.4 Europe Radiopharmaceutical Therapy Forecast by Country (2024-2029)
10.4.1 Germany Radiopharmaceutical Therapy Market Forecast
10.4.2 France Radiopharmaceutical Therapy Market Forecast
10.4.3 UK Radiopharmaceutical Therapy Market Forecast
10.4.4 Italy Radiopharmaceutical Therapy Market Forecast
10.4.5 Russia Radiopharmaceutical Therapy Market Forecast
10.5 Middle East & Africa Radiopharmaceutical Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Radiopharmaceutical Therapy Market Forecast
10.5.2 South Africa Radiopharmaceutical Therapy Market Forecast
10.5.3 Israel Radiopharmaceutical Therapy Market Forecast
10.5.4 Turkey Radiopharmaceutical Therapy Market Forecast
10.5.5 GCC Countries Radiopharmaceutical Therapy Market Forecast
10.6 Global Radiopharmaceutical Therapy Forecast by Type (2024-2029)
10.7 Global Radiopharmaceutical Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Information
11.1.2 Bracco Imaging Radiopharmaceutical Therapy Product Offered
11.1.3 Bracco Imaging Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bracco Imaging Main Business Overview
11.1.5 Bracco Imaging Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Radiopharmaceutical Therapy Product Offered
11.2.3 Bayer Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Information
11.3.2 Mallinckrodt Radiopharmaceutical Therapy Product Offered
11.3.3 Mallinckrodt Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Mallinckrodt Main Business Overview
11.3.5 Mallinckrodt Latest Developments
11.4 Nordion
11.4.1 Nordion Company Information
11.4.2 Nordion Radiopharmaceutical Therapy Product Offered
11.4.3 Nordion Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Nordion Main Business Overview
11.4.5 Nordion Latest Developments
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Information
11.5.2 Triad Isotopes Radiopharmaceutical Therapy Product Offered
11.5.3 Triad Isotopes Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Triad Isotopes Main Business Overview
11.5.5 Triad Isotopes Latest Developments
11.6 Lantheus
11.6.1 Lantheus Company Information
11.6.2 Lantheus Radiopharmaceutical Therapy Product Offered
11.6.3 Lantheus Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Lantheus Main Business Overview
11.6.5 Lantheus Latest Developments
11.7 IBA Group
11.7.1 IBA Group Company Information
11.7.2 IBA Group Radiopharmaceutical Therapy Product Offered
11.7.3 IBA Group Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 IBA Group Main Business Overview
11.7.5 IBA Group Latest Developments
11.8 GE Healthcare
11.8.1 GE Healthcare Company Information
11.8.2 GE Healthcare Radiopharmaceutical Therapy Product Offered
11.8.3 GE Healthcare Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 GE Healthcare Main Business Overview
11.8.5 GE Healthcare Latest Developments
11.9 China Isotope & Radiation
11.9.1 China Isotope & Radiation Company Information
11.9.2 China Isotope & Radiation Radiopharmaceutical Therapy Product Offered
11.9.3 China Isotope & Radiation Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 China Isotope & Radiation Main Business Overview
11.9.5 China Isotope & Radiation Latest Developments
11.10 Jubilant Pharma
11.10.1 Jubilant Pharma Company Information
11.10.2 Jubilant Pharma Radiopharmaceutical Therapy Product Offered
11.10.3 Jubilant Pharma Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Jubilant Pharma Main Business Overview
11.10.5 Jubilant Pharma Latest Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Information
11.11.2 Eli Lilly Radiopharmaceutical Therapy Product Offered
11.11.3 Eli Lilly Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Eli Lilly Main Business Overview
11.11.5 Eli Lilly Latest Developments
11.12 Advanced Accelerator Applications
11.12.1 Advanced Accelerator Applications Company Information
11.12.2 Advanced Accelerator Applications Radiopharmaceutical Therapy Product Offered
11.12.3 Advanced Accelerator Applications Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Advanced Accelerator Applications Main Business Overview
11.12.5 Advanced Accelerator Applications Latest Developments
11.13 SIEMENS
11.13.1 SIEMENS Company Information
11.13.2 SIEMENS Radiopharmaceutical Therapy Product Offered
11.13.3 SIEMENS Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 SIEMENS Main Business Overview
11.13.5 SIEMENS Latest Developments
11.14 Dongcheng
11.14.1 Dongcheng Company Information
11.14.2 Dongcheng Radiopharmaceutical Therapy Product Offered
11.14.3 Dongcheng Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Dongcheng Main Business Overview
11.14.5 Dongcheng Latest Developments
11.15 Navidea
11.15.1 Navidea Company Information
11.15.2 Navidea Radiopharmaceutical Therapy Product Offered
11.15.3 Navidea Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Navidea Main Business Overview
11.15.5 Navidea Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceutical Therapy Market Size 2018-2029
2.1.2 Radiopharmaceutical Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Radiopharmaceutical Therapy Segment by Type
2.2.1 Actinium-225
2.2.2 Lutetium-177
2.2.3 Radium-223
2.2.4 Holmium-166
2.2.5 Other
2.3 Radiopharmaceutical Therapy Market Size by Type
2.3.1 Radiopharmaceutical Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
2.4 Radiopharmaceutical Therapy Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceutical Therapy Market Size by Application
2.5.1 Radiopharmaceutical Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
3 RADIOPHARMACEUTICAL THERAPY MARKET SIZE BY PLAYER
3.1 Radiopharmaceutical Therapy Market Size Market Share by Players
3.1.1 Global Radiopharmaceutical Therapy Revenue by Players (2018-2023)
3.1.2 Global Radiopharmaceutical Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Radiopharmaceutical Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICAL THERAPY BY REGIONS
4.1 Radiopharmaceutical Therapy Market Size by Regions (2018-2023)
4.2 Americas Radiopharmaceutical Therapy Market Size Growth (2018-2023)
4.3 APAC Radiopharmaceutical Therapy Market Size Growth (2018-2023)
4.4 Europe Radiopharmaceutical Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Radiopharmaceutical Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Radiopharmaceutical Therapy Market Size by Country (2018-2023)
5.2 Americas Radiopharmaceutical Therapy Market Size by Type (2018-2023)
5.3 Americas Radiopharmaceutical Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceutical Therapy Market Size by Region (2018-2023)
6.2 APAC Radiopharmaceutical Therapy Market Size by Type (2018-2023)
6.3 APAC Radiopharmaceutical Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Radiopharmaceutical Therapy by Country (2018-2023)
7.2 Europe Radiopharmaceutical Therapy Market Size by Type (2018-2023)
7.3 Europe Radiopharmaceutical Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceutical Therapy by Region (2018-2023)
8.2 Middle East & Africa Radiopharmaceutical Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Radiopharmaceutical Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RADIOPHARMACEUTICAL THERAPY MARKET FORECAST
10.1 Global Radiopharmaceutical Therapy Forecast by Regions (2024-2029)
10.1.1 Global Radiopharmaceutical Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Radiopharmaceutical Therapy Forecast
10.1.3 APAC Radiopharmaceutical Therapy Forecast
10.1.4 Europe Radiopharmaceutical Therapy Forecast
10.1.5 Middle East & Africa Radiopharmaceutical Therapy Forecast
10.2 Americas Radiopharmaceutical Therapy Forecast by Country (2024-2029)
10.2.1 United States Radiopharmaceutical Therapy Market Forecast
10.2.2 Canada Radiopharmaceutical Therapy Market Forecast
10.2.3 Mexico Radiopharmaceutical Therapy Market Forecast
10.2.4 Brazil Radiopharmaceutical Therapy Market Forecast
10.3 APAC Radiopharmaceutical Therapy Forecast by Region (2024-2029)
10.3.1 China Radiopharmaceutical Therapy Market Forecast
10.3.2 Japan Radiopharmaceutical Therapy Market Forecast
10.3.3 Korea Radiopharmaceutical Therapy Market Forecast
10.3.4 Southeast Asia Radiopharmaceutical Therapy Market Forecast
10.3.5 India Radiopharmaceutical Therapy Market Forecast
10.3.6 Australia Radiopharmaceutical Therapy Market Forecast
10.4 Europe Radiopharmaceutical Therapy Forecast by Country (2024-2029)
10.4.1 Germany Radiopharmaceutical Therapy Market Forecast
10.4.2 France Radiopharmaceutical Therapy Market Forecast
10.4.3 UK Radiopharmaceutical Therapy Market Forecast
10.4.4 Italy Radiopharmaceutical Therapy Market Forecast
10.4.5 Russia Radiopharmaceutical Therapy Market Forecast
10.5 Middle East & Africa Radiopharmaceutical Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Radiopharmaceutical Therapy Market Forecast
10.5.2 South Africa Radiopharmaceutical Therapy Market Forecast
10.5.3 Israel Radiopharmaceutical Therapy Market Forecast
10.5.4 Turkey Radiopharmaceutical Therapy Market Forecast
10.5.5 GCC Countries Radiopharmaceutical Therapy Market Forecast
10.6 Global Radiopharmaceutical Therapy Forecast by Type (2024-2029)
10.7 Global Radiopharmaceutical Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Information
11.1.2 Bracco Imaging Radiopharmaceutical Therapy Product Offered
11.1.3 Bracco Imaging Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bracco Imaging Main Business Overview
11.1.5 Bracco Imaging Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Radiopharmaceutical Therapy Product Offered
11.2.3 Bayer Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Information
11.3.2 Mallinckrodt Radiopharmaceutical Therapy Product Offered
11.3.3 Mallinckrodt Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Mallinckrodt Main Business Overview
11.3.5 Mallinckrodt Latest Developments
11.4 Nordion
11.4.1 Nordion Company Information
11.4.2 Nordion Radiopharmaceutical Therapy Product Offered
11.4.3 Nordion Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Nordion Main Business Overview
11.4.5 Nordion Latest Developments
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Information
11.5.2 Triad Isotopes Radiopharmaceutical Therapy Product Offered
11.5.3 Triad Isotopes Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Triad Isotopes Main Business Overview
11.5.5 Triad Isotopes Latest Developments
11.6 Lantheus
11.6.1 Lantheus Company Information
11.6.2 Lantheus Radiopharmaceutical Therapy Product Offered
11.6.3 Lantheus Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Lantheus Main Business Overview
11.6.5 Lantheus Latest Developments
11.7 IBA Group
11.7.1 IBA Group Company Information
11.7.2 IBA Group Radiopharmaceutical Therapy Product Offered
11.7.3 IBA Group Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 IBA Group Main Business Overview
11.7.5 IBA Group Latest Developments
11.8 GE Healthcare
11.8.1 GE Healthcare Company Information
11.8.2 GE Healthcare Radiopharmaceutical Therapy Product Offered
11.8.3 GE Healthcare Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 GE Healthcare Main Business Overview
11.8.5 GE Healthcare Latest Developments
11.9 China Isotope & Radiation
11.9.1 China Isotope & Radiation Company Information
11.9.2 China Isotope & Radiation Radiopharmaceutical Therapy Product Offered
11.9.3 China Isotope & Radiation Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 China Isotope & Radiation Main Business Overview
11.9.5 China Isotope & Radiation Latest Developments
11.10 Jubilant Pharma
11.10.1 Jubilant Pharma Company Information
11.10.2 Jubilant Pharma Radiopharmaceutical Therapy Product Offered
11.10.3 Jubilant Pharma Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Jubilant Pharma Main Business Overview
11.10.5 Jubilant Pharma Latest Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Information
11.11.2 Eli Lilly Radiopharmaceutical Therapy Product Offered
11.11.3 Eli Lilly Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Eli Lilly Main Business Overview
11.11.5 Eli Lilly Latest Developments
11.12 Advanced Accelerator Applications
11.12.1 Advanced Accelerator Applications Company Information
11.12.2 Advanced Accelerator Applications Radiopharmaceutical Therapy Product Offered
11.12.3 Advanced Accelerator Applications Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Advanced Accelerator Applications Main Business Overview
11.12.5 Advanced Accelerator Applications Latest Developments
11.13 SIEMENS
11.13.1 SIEMENS Company Information
11.13.2 SIEMENS Radiopharmaceutical Therapy Product Offered
11.13.3 SIEMENS Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 SIEMENS Main Business Overview
11.13.5 SIEMENS Latest Developments
11.14 Dongcheng
11.14.1 Dongcheng Company Information
11.14.2 Dongcheng Radiopharmaceutical Therapy Product Offered
11.14.3 Dongcheng Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Dongcheng Main Business Overview
11.14.5 Dongcheng Latest Developments
11.15 Navidea
11.15.1 Navidea Company Information
11.15.2 Navidea Radiopharmaceutical Therapy Product Offered
11.15.3 Navidea Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Navidea Main Business Overview
11.15.5 Navidea Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Radiopharmaceutical Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Actinium-225
Table 3. Major Players of Lutetium-177
Table 4. Major Players of Radium-223
Table 5. Major Players of Holmium-166
Table 6. Major Players of Other
Table 7. Radiopharmaceutical Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Radiopharmaceutical Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
Table 10. Radiopharmaceutical Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Radiopharmaceutical Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
Table 13. Global Radiopharmaceutical Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Radiopharmaceutical Therapy Revenue Market Share by Player (2018-2023)
Table 15. Radiopharmaceutical Therapy Key Players Head office and Products Offered
Table 16. Radiopharmaceutical Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Radiopharmaceutical Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Radiopharmaceutical Therapy Market Size Market Share by Regions (2018-2023)
Table 21. Global Radiopharmaceutical Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Radiopharmaceutical Therapy Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Radiopharmaceutical Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Radiopharmaceutical Therapy Market Size Market Share by Country (2018-2023)
Table 25. Americas Radiopharmaceutical Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
Table 27. Americas Radiopharmaceutical Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
Table 29. APAC Radiopharmaceutical Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Radiopharmaceutical Therapy Market Size Market Share by Region (2018-2023)
Table 31. APAC Radiopharmaceutical Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
Table 33. APAC Radiopharmaceutical Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
Table 35. Europe Radiopharmaceutical Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Radiopharmaceutical Therapy Market Size Market Share by Country (2018-2023)
Table 37. Europe Radiopharmaceutical Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
Table 39. Europe Radiopharmaceutical Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Radiopharmaceutical Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Radiopharmaceutical Therapy Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Radiopharmaceutical Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Radiopharmaceutical Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Radiopharmaceutical Therapy
Table 48. Key Market Challenges & Risks of Radiopharmaceutical Therapy
Table 49. Key Industry Trends of Radiopharmaceutical Therapy
Table 50. Global Radiopharmaceutical Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Radiopharmaceutical Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Radiopharmaceutical Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Radiopharmaceutical Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Bracco Imaging Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 55. Bracco Imaging Radiopharmaceutical Therapy Product Offered
Table 56. Bracco Imaging Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Bracco Imaging Main Business
Table 58. Bracco Imaging Latest Developments
Table 59. Bayer Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 60. Bayer Radiopharmaceutical Therapy Product Offered
Table 61. Bayer Main Business
Table 62. Bayer Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Bayer Latest Developments
Table 64. Mallinckrodt Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 65. Mallinckrodt Radiopharmaceutical Therapy Product Offered
Table 66. Mallinckrodt Main Business
Table 67. Mallinckrodt Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Mallinckrodt Latest Developments
Table 69. Nordion Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 70. Nordion Radiopharmaceutical Therapy Product Offered
Table 71. Nordion Main Business
Table 72. Nordion Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Nordion Latest Developments
Table 74. Triad Isotopes Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 75. Triad Isotopes Radiopharmaceutical Therapy Product Offered
Table 76. Triad Isotopes Main Business
Table 77. Triad Isotopes Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Triad Isotopes Latest Developments
Table 79. Lantheus Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 80. Lantheus Radiopharmaceutical Therapy Product Offered
Table 81. Lantheus Main Business
Table 82. Lantheus Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Lantheus Latest Developments
Table 84. IBA Group Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 85. IBA Group Radiopharmaceutical Therapy Product Offered
Table 86. IBA Group Main Business
Table 87. IBA Group Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. IBA Group Latest Developments
Table 89. GE Healthcare Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 90. GE Healthcare Radiopharmaceutical Therapy Product Offered
Table 91. GE Healthcare Main Business
Table 92. GE Healthcare Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. GE Healthcare Latest Developments
Table 94. China Isotope & Radiation Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 95. China Isotope & Radiation Radiopharmaceutical Therapy Product Offered
Table 96. China Isotope & Radiation Main Business
Table 97. China Isotope & Radiation Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. China Isotope & Radiation Latest Developments
Table 99. Jubilant Pharma Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 100. Jubilant Pharma Radiopharmaceutical Therapy Product Offered
Table 101. Jubilant Pharma Main Business
Table 102. Jubilant Pharma Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Jubilant Pharma Latest Developments
Table 104. Eli Lilly Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 105. Eli Lilly Radiopharmaceutical Therapy Product Offered
Table 106. Eli Lilly Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. Eli Lilly Main Business
Table 108. Eli Lilly Latest Developments
Table 109. Advanced Accelerator Applications Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 110. Advanced Accelerator Applications Radiopharmaceutical Therapy Product Offered
Table 111. Advanced Accelerator Applications Main Business
Table 112. Advanced Accelerator Applications Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 113. Advanced Accelerator Applications Latest Developments
Table 114. SIEMENS Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 115. SIEMENS Radiopharmaceutical Therapy Product Offered
Table 116. SIEMENS Main Business
Table 117. SIEMENS Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. SIEMENS Latest Developments
Table 119. Dongcheng Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 120. Dongcheng Radiopharmaceutical Therapy Product Offered
Table 121. Dongcheng Main Business
Table 122. Dongcheng Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 123. Dongcheng Latest Developments
Table 124. Navidea Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 125. Navidea Radiopharmaceutical Therapy Product Offered
Table 126. Navidea Main Business
Table 127. Navidea Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 128. Navidea Latest Developments
Table 1. Radiopharmaceutical Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Actinium-225
Table 3. Major Players of Lutetium-177
Table 4. Major Players of Radium-223
Table 5. Major Players of Holmium-166
Table 6. Major Players of Other
Table 7. Radiopharmaceutical Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Radiopharmaceutical Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
Table 10. Radiopharmaceutical Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Radiopharmaceutical Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
Table 13. Global Radiopharmaceutical Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Radiopharmaceutical Therapy Revenue Market Share by Player (2018-2023)
Table 15. Radiopharmaceutical Therapy Key Players Head office and Products Offered
Table 16. Radiopharmaceutical Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Radiopharmaceutical Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Radiopharmaceutical Therapy Market Size Market Share by Regions (2018-2023)
Table 21. Global Radiopharmaceutical Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Radiopharmaceutical Therapy Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Radiopharmaceutical Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Radiopharmaceutical Therapy Market Size Market Share by Country (2018-2023)
Table 25. Americas Radiopharmaceutical Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
Table 27. Americas Radiopharmaceutical Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
Table 29. APAC Radiopharmaceutical Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Radiopharmaceutical Therapy Market Size Market Share by Region (2018-2023)
Table 31. APAC Radiopharmaceutical Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
Table 33. APAC Radiopharmaceutical Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
Table 35. Europe Radiopharmaceutical Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Radiopharmaceutical Therapy Market Size Market Share by Country (2018-2023)
Table 37. Europe Radiopharmaceutical Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
Table 39. Europe Radiopharmaceutical Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Radiopharmaceutical Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Radiopharmaceutical Therapy Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Radiopharmaceutical Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Radiopharmaceutical Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Radiopharmaceutical Therapy
Table 48. Key Market Challenges & Risks of Radiopharmaceutical Therapy
Table 49. Key Industry Trends of Radiopharmaceutical Therapy
Table 50. Global Radiopharmaceutical Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Radiopharmaceutical Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Radiopharmaceutical Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Radiopharmaceutical Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Bracco Imaging Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 55. Bracco Imaging Radiopharmaceutical Therapy Product Offered
Table 56. Bracco Imaging Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Bracco Imaging Main Business
Table 58. Bracco Imaging Latest Developments
Table 59. Bayer Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 60. Bayer Radiopharmaceutical Therapy Product Offered
Table 61. Bayer Main Business
Table 62. Bayer Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Bayer Latest Developments
Table 64. Mallinckrodt Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 65. Mallinckrodt Radiopharmaceutical Therapy Product Offered
Table 66. Mallinckrodt Main Business
Table 67. Mallinckrodt Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Mallinckrodt Latest Developments
Table 69. Nordion Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 70. Nordion Radiopharmaceutical Therapy Product Offered
Table 71. Nordion Main Business
Table 72. Nordion Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Nordion Latest Developments
Table 74. Triad Isotopes Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 75. Triad Isotopes Radiopharmaceutical Therapy Product Offered
Table 76. Triad Isotopes Main Business
Table 77. Triad Isotopes Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Triad Isotopes Latest Developments
Table 79. Lantheus Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 80. Lantheus Radiopharmaceutical Therapy Product Offered
Table 81. Lantheus Main Business
Table 82. Lantheus Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Lantheus Latest Developments
Table 84. IBA Group Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 85. IBA Group Radiopharmaceutical Therapy Product Offered
Table 86. IBA Group Main Business
Table 87. IBA Group Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. IBA Group Latest Developments
Table 89. GE Healthcare Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 90. GE Healthcare Radiopharmaceutical Therapy Product Offered
Table 91. GE Healthcare Main Business
Table 92. GE Healthcare Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. GE Healthcare Latest Developments
Table 94. China Isotope & Radiation Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 95. China Isotope & Radiation Radiopharmaceutical Therapy Product Offered
Table 96. China Isotope & Radiation Main Business
Table 97. China Isotope & Radiation Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. China Isotope & Radiation Latest Developments
Table 99. Jubilant Pharma Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 100. Jubilant Pharma Radiopharmaceutical Therapy Product Offered
Table 101. Jubilant Pharma Main Business
Table 102. Jubilant Pharma Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Jubilant Pharma Latest Developments
Table 104. Eli Lilly Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 105. Eli Lilly Radiopharmaceutical Therapy Product Offered
Table 106. Eli Lilly Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. Eli Lilly Main Business
Table 108. Eli Lilly Latest Developments
Table 109. Advanced Accelerator Applications Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 110. Advanced Accelerator Applications Radiopharmaceutical Therapy Product Offered
Table 111. Advanced Accelerator Applications Main Business
Table 112. Advanced Accelerator Applications Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 113. Advanced Accelerator Applications Latest Developments
Table 114. SIEMENS Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 115. SIEMENS Radiopharmaceutical Therapy Product Offered
Table 116. SIEMENS Main Business
Table 117. SIEMENS Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. SIEMENS Latest Developments
Table 119. Dongcheng Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 120. Dongcheng Radiopharmaceutical Therapy Product Offered
Table 121. Dongcheng Main Business
Table 122. Dongcheng Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 123. Dongcheng Latest Developments
Table 124. Navidea Details, Company Type, Radiopharmaceutical Therapy Area Served and Its Competitors
Table 125. Navidea Radiopharmaceutical Therapy Product Offered
Table 126. Navidea Main Business
Table 127. Navidea Radiopharmaceutical Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 128. Navidea Latest Developments
LIST OF FIGURES
Figure 1. Radiopharmaceutical Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radiopharmaceutical Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Radiopharmaceutical Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Radiopharmaceutical Therapy Sales Market Share by Country/Region (2022)
Figure 8. Radiopharmaceutical Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Radiopharmaceutical Therapy Market Size Market Share by Type in 2022
Figure 10. Radiopharmaceutical Therapy in Oncology
Figure 11. Global Radiopharmaceutical Therapy Market: Oncology (2018-2023) & ($ Millions)
Figure 12. Radiopharmaceutical Therapy in Cardiology
Figure 13. Global Radiopharmaceutical Therapy Market: Cardiology (2018-2023) & ($ Millions)
Figure 14. Radiopharmaceutical Therapy in Other
Figure 15. Global Radiopharmaceutical Therapy Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Radiopharmaceutical Therapy Market Size Market Share by Application in 2022
Figure 17. Global Radiopharmaceutical Therapy Revenue Market Share by Player in 2022
Figure 18. Global Radiopharmaceutical Therapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Radiopharmaceutical Therapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Radiopharmaceutical Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Radiopharmaceutical Therapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Radiopharmaceutical Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Radiopharmaceutical Therapy Value Market Share by Country in 2022
Figure 24. United States Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Radiopharmaceutical Therapy Market Size Market Share by Region in 2022
Figure 29. APAC Radiopharmaceutical Therapy Market Size Market Share by Type in 2022
Figure 30. APAC Radiopharmaceutical Therapy Market Size Market Share by Application in 2022
Figure 31. China Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Radiopharmaceutical Therapy Market Size Market Share by Country in 2022
Figure 38. Europe Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Radiopharmaceutical Therapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 61. China Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 65. India Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 68. France Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Radiopharmaceutical Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Radiopharmaceutical Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Radiopharmaceutical Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radiopharmaceutical Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Radiopharmaceutical Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Radiopharmaceutical Therapy Sales Market Share by Country/Region (2022)
Figure 8. Radiopharmaceutical Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Radiopharmaceutical Therapy Market Size Market Share by Type in 2022
Figure 10. Radiopharmaceutical Therapy in Oncology
Figure 11. Global Radiopharmaceutical Therapy Market: Oncology (2018-2023) & ($ Millions)
Figure 12. Radiopharmaceutical Therapy in Cardiology
Figure 13. Global Radiopharmaceutical Therapy Market: Cardiology (2018-2023) & ($ Millions)
Figure 14. Radiopharmaceutical Therapy in Other
Figure 15. Global Radiopharmaceutical Therapy Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Radiopharmaceutical Therapy Market Size Market Share by Application in 2022
Figure 17. Global Radiopharmaceutical Therapy Revenue Market Share by Player in 2022
Figure 18. Global Radiopharmaceutical Therapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Radiopharmaceutical Therapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Radiopharmaceutical Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Radiopharmaceutical Therapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Radiopharmaceutical Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Radiopharmaceutical Therapy Value Market Share by Country in 2022
Figure 24. United States Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Radiopharmaceutical Therapy Market Size Market Share by Region in 2022
Figure 29. APAC Radiopharmaceutical Therapy Market Size Market Share by Type in 2022
Figure 30. APAC Radiopharmaceutical Therapy Market Size Market Share by Application in 2022
Figure 31. China Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Radiopharmaceutical Therapy Market Size Market Share by Country in 2022
Figure 38. Europe Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Radiopharmaceutical Therapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Radiopharmaceutical Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Radiopharmaceutical Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Radiopharmaceutical Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 61. China Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 65. India Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 68. France Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Radiopharmaceutical Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Radiopharmaceutical Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Radiopharmaceutical Therapy Market Size Market Share Forecast by Application (2024-2029)
